Reduce your recruitment timelines

Using our efficient recruitment techniques, adaptive study designs and integrated protocols we can run hybrid studies reducing our sponsors’ drug development time.

Examples of our accelerated recruitment

Accurate costs projection. We conducted a FIH study of Lumasiran in March 2016. Our team helped to accelerate drug development using adaptive study design and provide accurate cost projections through efficient recruitment. Alnylam received marketing authorisation in April 2020.

In a study for Symptomatic Transthyretin Amyloid Cardiomyopathy, Richmond Pharmacology enrolled 11% of patients in a multi-centre study involving 104 global centres.

Reliability and operational scalability. Our in-house recruitment team enrolled 92 hypertensive patients for a global study on behalf of Alnylam, fulfilling 58% of the total cohort. Our patient networks enabled us to rapidly upscale recruitment and reduce the study timelines.

x

We enable rapid drug development

By swiftly adapting strategies to suit the unique demands of individual trials, we ensure resources are invested in the most appropriate recruitment tactics. Frequently recruiting more than our allotted cohort size in multi-centre studies, we enable our sponsors to complete enrolment early.

We are renowned for our recruitment capabilities.

Our dedicated in-house recruitment team delivers a personal service ensuring volunteers are engaged from the first contact to the last appointment.

Get in touch today

Why choose Richmond Pharmacology for Patient Recruitment in Early Phase Studies

TAP OR CLICK A BLOCK BELOW TO LEARN MORE

Strategic and efficient

You will experience a truly personal service.

Read more +

Diverse patient database

Our recruitment database is arguably the largest in Europe.

Read more +

Accurate timeline and cost predictability

We offer invaluable insight into study acceptability and suitability.

Read more +

Volunteer experience

By listening to the feedback of our volunteers, we make continuous improvements to the experience of our research participants.

Read more +

We enrol more patients safely to your study in a shorter time span using our streamlined procedures

Latest news

Clinical trials: how taking the pills can pay those bills.

April 20, 2022
The Guardian references Richmond Pharmacology in feature on reimbursement for clinical trial volunteers
Read more

Clinical trials and the patient perspective

May 6, 2022
Successful recruitment and retention of patients - an essential element to delivering clinical studies on time.
Read more

Events

The Future of Healthcare - March 2022

13:30 – 16:00, 22nd March 2022
Discover the intricacies of assessing abnormal liver functions in clinical trial volunteers and gain insights from the latest drug development trials using RNAi therapeutics.
View event